Tay-Sachs Awareness Month: Prioritize Your Health With Jscreen
ATLANTA, GA / ACCESSWIRE / September 9, 2024 / Shari Ungerleider and Myra Sack have one thing in common: they...
Pregnancy
New England Biolabs® Announces 2024 Passion in Science Awards® Recipients
Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,...
Carrot Fertility launches CarrotMatch for maternity, the first pregnancy navigation system to match members with the highest quality and most cost-effective providers for their unique needs
CarrotMatch eliminates frustrations and lowers costs while expanding support with virtual care teams, including doulas, midwives, grief counselors, nutritionists, and...
Real-Time Physiology in Cadavers: Is This an Oxymoron?
SANTA CLARA, Calif., Sept. 5, 2024 /PRNewswire/ -- Anatomage, Inc., today introduces upcoming upgrades to the Anatomage Table that simulate...
Clue and Headspace Announce Collaboration to Empower Women and People with Cycles to Take Control of their Mental Health
BERLIN, Germany, Aug. 15, 2024 /PRNewswire/ -- Clue, a leading menstrual and reproductive health tracking app, and Headspace, a leading...
Embr Labs, Recognized as Leading Menopause innovator by Femtech World, Launches on Amazon in the UK
BOSTON, Aug. 14, 2024 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading temperature wearable, today announced the...
Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a...
Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
Company gained CE Mark approval for four of its women’s health products and completed buildout of commercial team for its...
Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance
CAPLYTA Q2 2024 net product sales were $161.3 million, compared to $110.1 million for the same period in 2023, representing a...
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
WAKIX® (pitolisant) Net Revenue of $172.8 Million for Second Quarter 2024; ~29% Growth Year-over-Year Next Generation Pitolisant High-Dose (HD) Program...
Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
MIAMI, FL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Flo Health Secures More than $200M Investment from General Atlantic to Revolutionize Women’s Health; First Purely Digital Consumer Women’s Health App to Achieve Unicorn Status
Leading women's health app sets new benchmark in rapidly expanding femtech industry LONDON, July 30, 2024 /PRNewswire/ -- Flo Health, the...
Prostate Cancer Foundation Canada Announces Leadership Transition
Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp....
Veru to Participate in the BTIG Virtual Biotechnology Conference
MIAMI, FL, July 29, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
International OCD Foundation Honors Reality Star Scheana Shay for Raising OCD Awareness
ORLANDO, FL / ACCESSWIRE / July 28, 2024 / Reality television sensation Scheana Shay received international accolades Saturday, July 27,...
The Canadian Foundation for Women’s Health (CFWH) Launches Comprehensive Effort to Combat Maternal Morbidity and Mortality
As Canada's maternal health suffers from ongoing deficiencies, the foundation urges immediate prevention and intervention with a multifaceted approachOTTAWA, July...
Reunion Neuroscience Inc. Announces First Patient Dosed in Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression
MORRISTOWN, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries...
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®
First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,...
TENA Reveals America’s Silent Incontinence Epidemic
PHILADELPHIA, July 18, 2024 /PRNewswire/ -- Incontinence is often associated with the elderly and infirm but new research by TENA,...